Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Official siteFINANCIAL SERVICES • SHELL COMPANIES • NASDAQ
Market Cap: $264.62M
Last updated: Nov 17, 2026 at 4:00 PM ET
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Statistics
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market cap of $264.62M and an enterprise value of $264.60M. Its share count is down 27.57% from a year earlier.
Total Valuation
Enterprise value is 0.01% below the market cap, as cash exceeds debt.
| Market Cap | $264.62M |
|---|---|
| Enterprise Value | $264.60M |
| Close (Nov 17, 2026) | $10.90 |
Key Dates
| Last Earnings Date | Jun 30, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is up 5.55% over 52 weeks and trades 0.28% above its 50-day average.
| Beta (1Y) | 0.00 |
|---|---|
| 52-Week Change | +5.55% |
| 1-Month Change | +0.28% |
| 3-Month Change | +1.68% |
| 6-Month Change | +3.02% |
| Total Return (1Y) | +5.55% |
| Return vs SPY (1Y) | -5.99% |
| Max Drawdown (1Y) | -0.46% |
| Sharpe Ratio (1Y) | 2.94 |
| Correlation with SPY (1Y) | -0.01 |
| 50-Day Average | $10.87 |
| 200-Day Average | $10.66 |
| 52-Week Range | $10.32 to $10.91 |
| RSI (14 Days) | 68.3 |
| Average Volume (20 Days) | 14.37K |
Financial Position
Current assets cover 0.02x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 0.02x |
|---|---|
| Quick Ratio | 0.02x |
| Debt / Equity | 0.00x |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$2.47M |
| Pretax Income | $5.16M |
| Net Income | $5.16M |
| Reported EPS (TTM) | $0.19 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $17.01K |
|---|---|
| Total Debt | $0 |
| Net Cash | $17.01K |
| Net Cash Per Share | $0.00 |
| Working Capital | -$2.21M |
| Shareholder Equity | -$8.40M |
| Total Assets | $147.46M |
| Total Liabilities | $8.45M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$539.31K |
|---|---|
| FCF Per Share | -$0.02 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
DMAA does not pay a dividend.
| Earnings Yield | 1.71% |
|---|---|
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About DMAA
What is DMAA's market cap?
Drugs Made In America Acquisition Corp. Ordinary Shares has a market cap of $264.62M. Its enterprise value, which adds debt and subtracts cash, is $264.60M.
What is DMAA's P/E ratio?
Drugs Made In America Acquisition Corp. Ordinary Shares has a trailing P/E ratio of 58.6x.
How many shares of DMAA are outstanding?
Drugs Made In America Acquisition Corp. Ordinary Shares has 24.28M shares outstanding. The count is down 27.57% from a year earlier.
Does DMAA pay a dividend?
No. Drugs Made In America Acquisition Corp. Ordinary Shares does not pay a dividend.
How much debt does DMAA have?
Drugs Made In America Acquisition Corp. Ordinary Shares has $0 of total debt and $17.01K of cash and equivalents, a net cash position of $17.01K.
DMAA pages: Overview, Statistics, Competitors